Quest for the right Drug
גנטמיצין טבע 80 מ"ג / 2 מ"ל GENTAMICIN TEVA 80 MG/2 ML (GENTAMICIN AS SULFATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי, תוך-שרירי : I.V, I.M
צורת מינון:
תמיסה להזרקה : SOLUTION FOR INJECTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects The following CIOMS frequency rating is used, when applicable: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) ; not known (frequency cannot be estimated from the available data). Infections and infestations: Not known: antibiotic-associated colitis (including pseudomembranous colitis), superinfection (caused by gentamicin-resistant bacteria) Blood and lymphatic system disorders: Not known: anaemia, blood dyscrasias Immune system disorders: Not known: hypersensitivity (see section 4.4), anaphylaxis/anaphylactic reaction (including anaphylactic shock) Metabolism and nutrition disorders: Not known: hypomagnesaemia on prolonged therapy Psychiatric disorders: Not known: depression, hallucinations, confusion Nervous system disorders: Not known: central neuropathy (including convulsions, lethargy, encephalopathy), peripheral neuropathy Ear and labyrinth disorders: Not known: vestibular damage, transitory hearing loss, irreversible hearing loss, deafness, particularly after exposure to ototoxic drugs or in the presence of renal dysfunction (see section 4.4). Gastrointestinal disorders: Very common: vomiting Not known: stomatitis, nausea Hepatobiliary disorders: Not known: abnormal liver function, transaminases increased Skin and subcutaneous tissue disorders: Not known: Stevens-Johnson syndrome, toxic epidermal necrosis, rash, purpura, urticaria, pruritus Renal and urinary disorders: Very rare: acute renal failure, Fanconi-like syndrome in patients treated with a prolonged course of high dose Not known: nephrotoxicity (usually reversible) has been reported Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף